0001437749-24-003794.txt : 20240212
0001437749-24-003794.hdr.sgml : 20240212
20240212174751
ACCESSION NUMBER: 0001437749-24-003794
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Dong
CENTRAL INDEX KEY: 0001920163
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 24621647
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA, LTD.
STREET 2: 400 ALEXANDER PARK DRIVE, 4TH FLOOR
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4/A
1
rdgdoc.xml
FORM 4/A
X0508
4/A
2024-01-31
2024-02-02
0001668243
UroGen Pharma Ltd.
URGN
0001920163
Kim Dong
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Financial Officer
0
Ordinary Shares
2024-01-31
4
M
0
3333
A
35253
D
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
This amendment corrects and restates the Amount of Securities Beneficially Owned Following Reported Transaction reported in the original Form 4 filed on February 2, 2024.
/s/ Jason D. Smith, Attorney-in-Fact
2024-02-12